Categories: News

The Untold Story Releases Zhang Boli’s Short Documentary on the Battle Against the Pandemic

BEIJING, July 13, 2021 /PRNewswire/ — Zhang Boli, Chinese Academy of Engineering, and honorary president of Tianjin University of Traditional Chinese Medicine, is a fighter against COVID-19 with TCM. In August 2020, He won the national honorary title of “People’s Hero”.

This short documentary was produced by The Untold Story, and it mainly told Zhang’s story about battling against COVID-19 and cultivating a useful medical talents team.

In this video, in January 2020, Covid-19 broke out in the city of Wuhan. The seventy-year-old traditional Chinese medicine (TCM) expert Zhang Boli and his team rushed to the front lines to help.

At the beginning of Covid-19’s breakout, Zhang Boli leaded a medical team of more than 350 medical personnel from Tianjin and Jiangsu to station in Wuhan Jiangxia shelter hospital.

Under the promotion of Zhang Boli, traditional Chinese medicine intervened in the treatment of covid-19 patients in the whole process. All the 16 shelter hospitals in Wuhan distributed TCM prescriptions at the same time, and the utilization rate of TCM reached 90%. By March 10, 2020, 564 patients in Jiangxia shelter hospital were closed, and none of them became severe or die.

Zhang Boli said that China needed to cultivate a team of high-level medical talents who can fight and win at present and what we can do is to practice “basic skills”. This is a very important link to improve the professional ability of medical students.

Video – https://youtu.be/WyVZ01aC5TI
Logo – https://healthtechnologynet.com/wp-content/uploads/2021/07/The_Untold_Story_Logo.jpg

Contact: Ivy Shao
Tel:008610-68996566
E-mail:773800249@qq.com 
YouTube link: https://youtu.be/WyVZ01aC5TI 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-untold-story-releases-zhang-bolis-short-documentary-on-the-battle-against-the-pandemic-301332745.html

SOURCE The Untold Story

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

6 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

9 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

9 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

9 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

9 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

9 hours ago